Cargando…

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917

Detalles Bibliográficos
Autores principales: So, Michelle, O’Rourke, Colin, Bahnson, Henry T., Greenbaum, Carla J., Speake, Cate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372046/
https://www.ncbi.nlm.nih.gov/pubmed/32669415
http://dx.doi.org/10.2337/dci20-0016
_version_ 1783561233008427008
author So, Michelle
O’Rourke, Colin
Bahnson, Henry T.
Greenbaum, Carla J.
Speake, Cate
author_facet So, Michelle
O’Rourke, Colin
Bahnson, Henry T.
Greenbaum, Carla J.
Speake, Cate
author_sort So, Michelle
collection PubMed
description
format Online
Article
Text
id pubmed-7372046
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-73720462021-08-01 Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917 So, Michelle O’Rourke, Colin Bahnson, Henry T. Greenbaum, Carla J. Speake, Cate Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2020-08 2020-07-10 /pmc/articles/PMC7372046/ /pubmed/32669415 http://dx.doi.org/10.2337/dci20-0016 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle e-Letters: Comments and Responses
So, Michelle
O’Rourke, Colin
Bahnson, Henry T.
Greenbaum, Carla J.
Speake, Cate
Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
title Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
title_full Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
title_fullStr Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
title_full_unstemmed Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
title_short Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
title_sort response to comment on so et al. autoantibody reversion: changing risk categories in multiple-autoantibody–positive individuals. diabetes care 2020;43:913–917
topic e-Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372046/
https://www.ncbi.nlm.nih.gov/pubmed/32669415
http://dx.doi.org/10.2337/dci20-0016
work_keys_str_mv AT somichelle responsetocommentonsoetalautoantibodyreversionchangingriskcategoriesinmultipleautoantibodypositiveindividualsdiabetescare202043913917
AT orourkecolin responsetocommentonsoetalautoantibodyreversionchangingriskcategoriesinmultipleautoantibodypositiveindividualsdiabetescare202043913917
AT bahnsonhenryt responsetocommentonsoetalautoantibodyreversionchangingriskcategoriesinmultipleautoantibodypositiveindividualsdiabetescare202043913917
AT greenbaumcarlaj responsetocommentonsoetalautoantibodyreversionchangingriskcategoriesinmultipleautoantibodypositiveindividualsdiabetescare202043913917
AT speakecate responsetocommentonsoetalautoantibodyreversionchangingriskcategoriesinmultipleautoantibodypositiveindividualsdiabetescare202043913917